ALGN Align Technology
FY2025 10-K
Align Technology (ALGN) filed its fiscal year 2025 10-K annual report with the SEC on Feb 27, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Global med-device co: design/manufacture/market Invisalign clear aligners (~80% revenue), iTero scanners, and exocad CAD/CAM software via integrated Align Digital Platform
- • 2025 new launches: iTero Lumina Pro with NIRI technology (March), Align X-ray Insights AI-based caries detection in EU/UK (March), Invisalign MAOB for Class II teen patients (December)
Management Discussion & Analysis
- • Revenue $4,035M, up 0.9% YoY ($+$36M); Clear Aligner +0.5% to $3,245M, Systems & Services +2.7% to $790M
- • Gross margin 67.2% vs 70.0%; operating margin 13.5% vs 15.2%; Clear Aligner margin 31.9% vs 35.4%; Systems & Services margin 38.8% vs 35.0%
Risk Factors
- • Section 232 investigation by U.S. Dept of Commerce into PPE/medical device imports directly threatens Align's Mexico-manufactured clear aligners shipped to U.S.
- • iTero HQ in Israel near Hamas conflict zone; Mexico manufacturing exposed to drug cartel/gang activity disrupting production and logistics
Financial SummaryXBRL
Revenue
$4.0B
Net Income
$410M
Gross Margin
67.2%
Operating Margin
13.5%
Net Margin
10.2%
ROE
10.1%
Total Assets
$6.2B
EPS (Diluted)
$5.65
Operating Cash Flow
$593M
Source: XBRL data from Align Technology FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other Align Technology Annual Reports
Get deeper insights on Align Technology
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.